Protein variability in cerebrospinal fluid and its possible implications for neurological protein biomarker research

The technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer’s disease

(2018) Bianca A. Trombetta et al.   PLoS One

Identification of SPARC-like 1 Protein as Part of a Biomarker Panel for Alzheimer's Disease in Cerebrospinal Fluid

(2018) Baharak Vafadar-Isfahani et al.   JOURNAL OF ALZHEIMERS DISEASE

BioInfra.Prot: A comprehensive proteomics workflow including data standardization, protein inference, expression analysis and data publication

(2017) Michael Turewicz et al.   JOURNAL OF BIOTECHNOLOGY

Identification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomics

(2017) N.K. Magdalinou et al.   PARKINSONISM & RELATED DISORDERS

CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative study

(2016) Ju-Hee Kang et al.   ACTA NEUROPATHOLOGICA

Regulation of cerebrospinal fluid (CSF) flow in neurodegenerative, neurovascular and neuroinflammatory disease

(2016) Matthew J. Simon et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Diagnosis of Neurodegenerative Diseases: The Clinical Approach

(2016) Manuel Gómez-Río et al.   Current Alzheimer Research

Variability of biomarkers in patients with chronic heart failure and healthy controls

(2016) Wouter C. Meijers et al.   EUROPEAN JOURNAL OF HEART FAILURE

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

(2016) Bob Olsson et al.   LANCET NEUROLOGY

Protein biomarkers in Parkinson's disease: Focus on cerebrospinal fluid markers and synaptic proteins

(2016) Steffen Halbgebauer et al.   MOVEMENT DISORDERS

A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer’s disease pathology

(2016) R W Paterson et al.   Translational Psychiatry

Identification of brain-enriched proteins in the cerebrospinal fluid proteome by LC-MS/MS profiling and mining of the Human Protein Atlas

(2016) Ilijana Begcevic et al.   Clinical Proteomics

A balanced view of the cerebrospinal fluid composition and functions: Focus on adult humans

(2015) Reynold Spector et al.   EXPERIMENTAL NEUROLOGY

Parkinson's disease

(2015) Lorraine V Kalia et al.   LANCET

Prediagnostic presentations of Parkinson's disease in primary care: a case-control study

(2015) Anette Schrag et al.   LANCET NEUROLOGY

Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay

(2015) Wendy E. Heywood et al.   Molecular Neurodegeneration

Disease-modifying strategies for Parkinson's disease

(2015) Lorraine V. Kalia et al.   MOVEMENT DISORDERS

Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease

(2014) Mirjana Babić et al.   CROATIAN MEDICAL JOURNAL

Cerebrospinal fluid inflammatory markers in patients with multiple sclerosis: a pilot study

(2014) Z. Matejčíková et al.   JOURNAL OF NEURAL TRANSMISSION

Accurate Proteome-wide Label-free Quantification by Delayed Normalization and Maximal Peptide Ratio Extraction, Termed MaxLFQ

(2014) Jürgen Cox et al.   MOLECULAR & CELLULAR PROTEOMICS

Huntington disease: natural history, biomarkers and prospects for therapeutics

(2014) Christopher A. Ross et al.   Nature Reviews Neurology

Combined enrichment of neuromelanin granules and synaptosomes from human substantia nigra pars compacta tissue for proteomic analysis

(2013) S. Plum et al.   Journal of Proteomics

Fluid biomarkers in Alzheimer’s disease – current concepts

(2013) Christoffer Rosén et al.   Molecular Neurodegeneration

Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort

(2013) B. Mollenhauer et al.   NEUROLOGY

Detection of Patient Subgroups with Differential Expression in Omics Data: A Comprehensive Comparison of Univariate Measures

(2013) Maike Ahrens et al.   PLoS One

Cerebrospinal fluid proteome comparison between multiple sclerosis patients and controls

(2012) A. C. Kroksveen et al.   ACTA NEUROLOGICA SCANDINAVICA

Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders

(2012) Sara Hall et al.   ARCHIVES OF NEUROLOGY

Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRM

(2012) Ann C. Kroksveen et al.   Journal of Proteomics

More than 100,000 Detectable Peptide Species Elute in Single Shotgun Proteomics Runs but the Majority is Inaccessible to Data-Dependent LC−MS/MS

(2011) Annette Michalski et al.   JOURNAL OF PROTEOME RESEARCH

Andromeda: A Peptide Search Engine Integrated into the MaxQuant Environment

(2011) Jürgen Cox et al.   JOURNAL OF PROTEOME RESEARCH

Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis

(2010) Manuel Comabella et al.   BRAIN

Quantitative Proteomics and Metabolomics Analysis of Normal Human Cerebrospinal Fluid Samples*

(2010) Marcel P. Stoop et al.   MOLECULAR & CELLULAR PROTEOMICS

Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases

(2009) Guo Nan Yin et al.   BRAIN RESEARCH

MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification

(2008) Jürgen Cox et al.   NATURE BIOTECHNOLOGY

Multiple sclerosis-related proteins identified in cerebrospinal fluid by advanced mass spectrometry

(2008) Marcel P. Stoop et al.   PROTEOMICS